Semaglutide
A GLP-1 receptor agonist prescribed for type 2 diabetes management (Ozempic, Rybelsus) or chronic weight management (Wegovy).
Semaglutide works by mimicking the natural GLP-1 hormone, signaling the brain to reduce appetite and slowing the digestive process.
It is available in both an injectable form (Ozempic and Wegovy) and a daily oral pill (Rybelsus). When prescribed for weight loss under the brand name Wegovy, it is combined with a reduced-calorie diet and increased physical activity.
It has become one of the most widely prescribed medications in telehealth weight loss programs.